Hematology cost per reportable results (CPRR)
Ended Purchase Order Awarded Last action
- Contract number
- W81K0020P0191
- Awardee
-
Sysmex America, Inc. UEI RCK2KP74XJF1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,084,037
Award facts
- Opportunity
-
- Hematology Cost Per Reportable Pre-Solicitation · W81K0020Q0084 · Posted May 14, 2020
- Hematology Cost Per Reportable Award Notice · Posted Jul 1, 2020
- Hematology Cost Per Reportable Solicitation · Posted May 21, 2020
- Contract value 78% obligated
-
- $1,084,036.55 Current, with exercised options
- $1,386,925.39 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Prairie View, IL 60069, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $56,800 | |
| Funding Only Action | -$154,870 | |
| Supplemental Agreement for work within scope | $146,683 | |
| Funding Only Action | $296,357 | |
| Supplemental Agreement for work within scope | $48,280 | |
| Exercise an Option | $0 | |
| Funding Only Action | $289,825 | |
| Funding Only Action | $79,795 | |
| Funding Only Action | -$142,000 | |
| Exercise an Option | $0 | |
| Funding Only Action | $283,296 | |
| Funding Only Action | -$89,935 | |
| Exercise an Option | $0 | |
| Funding Only Action | $269,806 | |
| Original award | $0 |
Show all 15
About this award
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Sysmex America, Inc., a U.S. subsidiary of the Japanese clinical laboratory equipment manufacturer Sysmex Corporation. The contract, valued at $1,386,925.39, is for hematology testing services on a cost-per-reportable-result basis for the Department of Pathology and Area Laboratory Services at the William Beaumont Army Medical Center and associated clinics in Fort Bliss, Texas. The contract has an ultimate completion date of September 30, 2025.
The contract was awarded as a result of a full and open competition solicitation (W81K0020Q0084) under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, with no set-aside designation. Sysmex America holds several Indefinite Delivery Vehicles with federal agencies like the Department of Veterans Affairs and Department of Justice to streamline the procurement of hematology analyzers, reagents, and associated services.
Quick answers
Who was awarded contract W81K0020P0191?
W81K0020P0191 was awarded to Sysmex America, Inc. by Medical Command (Department of the Army) on October 1, 2020.
How much is contract W81K0020P0191 worth?
The government has obligated $1,084,037 on W81K0020P0191. Its potential value, with all options, is $1,386,925.
Which agency awarded contract W81K0020P0191?
Medical Command (Department of the Army) awarded W81K0020P0191, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0020P0191 competed?
The extent of competition for W81K0020P0191 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award